Cargando…
Improving acarbose production and eliminating the by-product component C with an efficient genetic manipulation system of Actinoplanes sp. SE50/110
The α-glucosidase inhibitor acarbose is commercially produced by Actinoplanes sp. and used as a potent drug in the treatment of type-2 diabetes. In order to improve the yield of acarbose, an efficient genetic manipulation system for Actinoplanes sp. was established. The conjugation system between E....
Autores principales: | Zhao, Qinqin, Xie, Huixin, Peng, Yao, Wang, Xinran, Bai, Linquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851932/ https://www.ncbi.nlm.nih.gov/pubmed/29552655 http://dx.doi.org/10.1016/j.synbio.2017.11.005 |
Ejemplares similares
-
The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110
por: Schwientek, Patrick, et al.
Publicado: (2012) -
Reconstruction and in silico analysis of an Actinoplanes sp. SE50/110 genome-scale metabolic model for acarbose production
por: Wang, Yali, et al.
Publicado: (2015) -
The expression of the acarbose biosynthesis gene cluster in Actinoplanes sp. SE50/110 is dependent on the growth phase
por: Droste, Julian, et al.
Publicado: (2020) -
The 4-α-Glucanotransferase AcbQ Is Involved in Acarbose Modification in Actinoplanes sp. SE50/110
por: Nölting, Sophia, et al.
Publicado: (2023) -
Evaluation of vector systems and promoters for overexpression of the acarbose biosynthesis gene acbC in Actinoplanes sp. SE50/110
por: Schaffert, Lena, et al.
Publicado: (2019)